Ads
related to: ms pathways betaseron- MS Early Signs & Symptoms
Get a Free Multiple Sclerosis Guide
Learn About MS Signs & Symptoms
- Progressive MS
Download Our Free Information Guide
Discover MS Symptoms & Treatment
- Transverse Myelitis
Learn About Transverse Myelitis.
Download Our Free Treatment Guide.
- Multiple Sclerosis
Download a Free MS Treatment Guide
Learn More About Multiple Sclerosis
- Need a Second Opinion?
Put Our Expertise to Work for You.
Get a Virtual Second Opinion Today.
- Relapsing MS
Learn About Relapsing MS.
Download a Free Treatment Guide.
- MS Early Signs & Symptoms
thorne.com has been visited by 10K+ users in the past month
Search results
Results from the Go Local Guru Content Network
Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells, while interferon beta-1b is produced in modified E. coli. Some research indicates that interferon injections may result in an 18–38% reduction in the rate of MS relapses.
Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile.
Multiple sclerosis can be pathologically defined as the presence of distributed glial scars (or sclerosis) in the central nervous system disseminated in time (DIT) and space (DIS). The gold standard for MS diagnosis is pathological correlation, though given its limited availability, other diagnosis methods are normally used. [3]
Interferon beta-1a and interferon beta-1b are used to treat and control multiple sclerosis, an autoimmune disorder. This treatment may help in reducing attacks in relapsing-remitting multiple sclerosis and slowing disease progression and activity in secondary progressive multiple sclerosis.
Multiple sclerosis is an autoimmune disease, primarily mediated by T-cells. [15] The three main characteristics of MS are the formation of lesions in the central nervous system (also called plaques), inflammation, and the destruction of myelin sheaths of neurons.
The typical path to approval in the 21st century may include basic research leading to understanding of mechanisms of disease progression and prevention such as chemical pathways, or candidate medications that aid or interfere with such pathways, which may be tested in vitro or in an animal model.
Ad
related to: ms pathways betaseron